Evidence map›Paper›PMID 37294311›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2023

Symptomatic vs. non-symptomatic device-related thrombus after LAAC: a sub-analysis from the multicenter EUROC-DRT registry.

Vivian Vij, Ignacio Cruz-González, Roberto Galea, Kerstin Piayda, Dominik Nelles, Lara Vogt, Steffen Gloekler, Monika Fürholz, Bernhard Meier, Lorenz Räber and 38 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Catheter based left atrial appendage closure in-hospital outcomes in Germany from 2016 to 2020.Clinical research in cardiology : official journal of the German Cardiac Society · 2024
    Article
  3. Article
  4. Safety of dobutamine or adenosine stress cardiac magnetic resonance imaging in patients with left ventricular thrombus.Clinical research in cardiology : official journal of the German Cardiac Society · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

48 authors at 20 institutions in 8 countries.

Vivian Vij *Department of Cardiology, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Ignacio Cruz-González *University Hospital of Salamanca, CIBER CV, IBSAL, Salamanca, Spain.
Roberto GaleaUniversity Hospital Bern, Bern, Switzerland.
Kerstin PiaydaCardioVasculäres Centrum, Frankfurt, Germany.
Dominik NellesDepartment of Cardiology, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Lara VogtDepartment of Cardiology, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Steffen GloeklerUniversity Hospital Bern, Bern, Switzerland.
Monika FürholzUniversity Hospital Bern, Bern, Switzerland.
Bernhard MeierUniversity Hospital Bern, Bern, Switzerland.
Lorenz RäberUniversity Hospital Bern, Bern, Switzerland.
Gilles O'HaraQuebec Heart and Lung Institute, Laval University, Quebec City, Canada.
Dabit ArzamendiHospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Victor AgudeloHospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Lluis AsmaratsQuebec Heart and Lung Institute, Laval University, Quebec City, Canada.
Xavier FreixaHospital Clinic Barcelona, Barcelona, Spain.
Eduardo Flores-UmanzorHospital Clinic Barcelona, Barcelona, Spain.
Ole De BackerRigshospitalet, University Hospital Copenhagen, Copenhagen, Denmark.
Lars SondergaardRigshospitalet, University Hospital Copenhagen, Copenhagen, Denmark.
Luis Nombela-FrancoHospital Clinico San Carlos Madrid, Madrid, Spain.
Angela McInerneyHospital Clinico San Carlos Madrid, Madrid, Spain.
Pablo SalinasHospital Clinico San Carlos Madrid, Madrid, Spain.
Kasper KorsholmAarhus University Hospital, Aarhus, Denmark.
Jens Erik Nielsen-KudskAarhus University Hospital, Aarhus, Denmark.
Shazia AfzalUniversity Hospital Düsseldorf, Düsseldorf, Germany.
Tobias ZeusUniversity Hospital Düsseldorf, Düsseldorf, Germany.
Felix OperhalskiAgaplesion Bethanien Krankenhaus, CBB, Frankfurt, Germany.
Boris SchmidtAgaplesion Bethanien Krankenhaus, CBB, Frankfurt, Germany.
Gilles MontalescotACTION Study Group, Pitié-Salpêtrière Hospital (AP-HP), Sorbonne University, Paris, France.
Paul GuedeneyACTION Study Group, Pitié-Salpêtrière Hospital (AP-HP), Sorbonne University, Paris, France.
Xavier IriartUniversity Hospital Bordeaux, Bordeaux, France.
Noelie MitonUniversity Hospital Bordeaux, Bordeaux, France.
Jacqueline SawVancouver General Hospital, Vancouver, Canada.
Thomas GilhoferUniversity Hospital Zurich, Zurich, Switzerland.
Laurent FauchierUniversity Hospital Tours, Tours, France.
Egzon VeliqiSt. Georg Hospital Hamburg, Hamburg, Germany.
Felix MeinckeSt. Georg Hospital Hamburg, Hamburg, Germany.
Nils PetriUniversity Hospital Würzburg, Würzburg, Germany.
Peter NordbeckUniversity Hospital Würzburg, Würzburg, Germany.
Rocio Gonzalez-FerreiroUniversity Hospital of Salamanca, CIBER CV, IBSAL, Salamanca, Spain.
Deepak L BhattMount Sinai Heart, Mount Sinai Hospital, New York, USA.
Alessandra LaricchiaDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Antonio MangieriDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Heyder OmranMarienkrankenhaus, Bonn, Germany.
Jan Wilko SchrickelDepartment of Cardiology, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Josep Rodes-CabauQuebec Heart and Lung Institute, Laval University, Quebec City, Canada.
Georg NickenigDepartment of Cardiology, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Horst SievertCardioVasculäres Centrum, Frankfurt, Germany.
Alexander SedaghatDepartment of Cardiology, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany. Alexander.sedaghat@ukbonn.de.ORCID http://orcid.org/0000-0001-7015-1056
University Hospital Bonn · DEUniversity Hospital of Bern · CHHospital Clínico San Carlos · ESHospital de Sant Pau · ESAarhus University Hospital · DKAgaplesion Bethanien Krankenhaus · DEAsklepios Klinik St. Georg · DEBordeaux Population Health · FRCardiovascular Center Frankfurt · DECentro de Investigación en Red en Enfermedades Cardiovasculares · ESDüsseldorf University Hospital · DEHospital Clínic de Barcelona · ESHumanitas University · ITRigshospitalet · DKSorbonne Université · FRUniversitätsklinikum Würzburg · DEUniversité Laval · CAMarienkrankenhaus Hamburg · DEMount Sinai Hospital · USUniversité de Tours · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDevice-related thrombus (DRT) after left atrial appendage closure (LAAC) is associated with adverse outcomes, i.e. ischemic stroke or systemic embolism (SE). Data on predictors of stroke/SE in the context of DRT are limited.

aimsThis study aimed to identify predisposing factors for stroke/SE in DRT patients. In addition, the temporal connection of stroke/SE to DRT diagnosis was analyzed.

methodsThe EUROC-DRT registry included 176 patients, in whom DRT after LAAC were diagnosed. Patients with symptomatic DRT, defined as stroke/SE in the context of DRT diagnosis, were compared against patients with non-symptomatic DRT. Baseline characteristics, anti-thrombotic regimens, device position, and timing of stroke/SE were compared.

resultsStroke/SE occurred in 25/176 (14.2%) patients diagnosed with DRT (symptomatic DRT). Stroke/SE occurred after a median of 198 days (IQR 37-558) after LAAC. In 45.8% stroke/SE occurred within one month before/after DRT diagnosis (DRT-related stroke). Patients with symptomatic DRT had lower left ventricular ejection fractions (50.0 ± 9.1% vs. 54.2 ± 11.0%, p = 0.03) and higher rates of non-paroxysmal atrial fibrillation (84.0% vs. 64.9%, p = 0.06). Other baseline parameters and device positions were not different. Most ischemic events occurred among patients with single antiplatelet therapy (50%), however, stroke/SE was also observed under dual antiplatelet therapy (25%) or oral anticoagulation (20%).

conclusionStroke/SE are documented in 14.2% and occur both in close temporal relation to the DRT finding and chronologically independently therefrom. Identification of risk factors remains cumbersome, putting all DRT patients at substantial risk for stroke/SE. Further studies are necessary to minimize the risk of DRT and ischemic events.

Indexed as

Atrial AppendageAtrial FibrillationStrokeThrombosisHumansRegistriesTreatment OutcomeAtrial fibrillationDevice-related thrombusLeft atrial appendage closureStroke

Identifiers

PMID37294311
PMCPMC10697873
OpenAlexW4379967515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.